🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs
5,568

Quick answer

Oncology: NovaPharmaNews indexes 5,568 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Page 108 of 116

  1. WP1220

    Moleculin Biotech

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides

    phase 1 small molecule completed

    1 trial

  2. WSK-IM05 (4×10^10 vp)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HPV-positive Oropharyngeal Squamous Cell Carcinoma

    phase 1 mab active

    1 trial

  3. WT1-loaded CBDC Vaccine

    AXIM BIOTECHNOLOGIES, INC.

    AML: Acute Myeloid Leukemia/ cancer of blood and bone marrow

    phase 1 small molecule active

    1 trial

  4. WT1-sensitized T cells

    Evidence Based Cataract Study Group

    Leukemia

    phase 1 mab completed

    1 trial

  5. WTX-124

    Werewolf Therapeutics

    Metastatic Solid Tumor

    phase 1 small molecule active

    1 trial

  6. X4P-001

    X4 Pharmaceuticals, Inc

    Melanoma

    phase 1 small molecule completed

    1 trial

  7. YMN-A02 100μg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  8. YMN101

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 mab active

    1 trial

  9. Yang Yin Fu Zheng Jie Du therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial

  10. Z650

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Pancreatic Cancer

    phase 1 small molecule terminated

    1 trial

  11. ZG0895 Hydrochloride for Injection

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  12. ZIO-101

    Alaunos Therapeutics

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  13. ZIO-101 (Darinaparsin)

    Alaunos Therapeutics

    Acute Leukemia

    phase 1 small molecule completed

    1 trial

  14. ZIO-101 (Darinaparsin)

    Alaunos Therapeutics

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  15. ZIO-101-C (Darinaparsin)

    Alaunos Therapeutics

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  16. ZIO-101-C (Darinaparsin)

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  17. ZIO-201

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  18. ZIO-201-T and doxorubicin

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  19. ZN-c3

    Zentalis Pharmaceuticals

    Tumors

    phase 1 small molecule terminated

    1 trial

  20. ZN-c3

    Zentalis Pharmaceuticals

    Metastatic Colorectal Cancer

    phase 1 small molecule terminated

    1 trial

  21. ZN-d5

    Zentalis Pharmaceuticals

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  22. ZW25 (Zanidatamab)

    Jazz Pharmaceuticals Ireland Limited

    HER2-expressing Cancers

    phase 1 small molecule completed

    1 trial

  23. Zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  24. Ziftomenib

    Kura Oncology

    Relapsed/Refractory KMT2A-r Acute Leukemia

    phase 1 small molecule active

    1 trial

  25. Ziftomenib

    Kura Oncology

    Refractory Acute Leukemia

    phase 1 small molecule active

    1 trial

  26. Ziftomenib

    Kura Oncology

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  27. Ziftomenib, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Solu-Cortef Powder for Solution for Injection or Infusion 100 mg

    AXIM BIOTECHNOLOGIES, INC.

    Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Acute Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  28. Zimberelimab

    Arcus Biosciences

    Head and Neck Cancer

    phase 1 small molecule terminated

    1 trial

  29. Zunsemetinib

    Aclaris Therapeutics

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 1 small molecule active

    1 trial

  30. [14C] Subasumstat

    Takeda

    Solid Tumors

    phase 1 small molecule terminated

    1 trial

  31. [14C]-BMS986504 Mass Balance Study in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  32. [14C]TGRX-326

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  33. [177Lu]Lu-XT117

    The First People's Hospital of Lianyungang

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  34. [18F]-αvβ6-BP

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 small molecule active

    1 trial

  35. [18F]F-AraG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cancer

    phase 1 small molecule active

    1 trial

  36. [18F]fluoro-PEG-folate PET/CT scan

    BRIGHT MINDS BIOSCIENCES INC.

    Epithelial Ovarian Cancer

    phase 1 other terminated

    1 trial

  37. [203Pb]VMT-α-NET

    Perspective Therapeutics

    Neuroendocrine Tumor Grade 2

    phase 1 small molecule active

    1 trial

  38. [203Pb]VMT01

    Perspective Therapeutics

    Melanoma (Skin)

    phase 1 small molecule completed

    1 trial

  39. [212Pb] VMT-α-NET

    Perspective Therapeutics

    Neuroendocrine Tumors

    phase 1 small molecule active

    1 trial

  40. [225Ac]Ac-AKY-1189 (therapeutic)

    Aktis Oncology

    Urothelial Carcinoma Bladder

    phase 1 small molecule active

    1 trial

  41. [225Ac]Ac-AKY-2519 (therapeutic)

    Aktis Oncology

    Castration Resistant Metastatic Prostate Cancer

    phase 1 small molecule active

    1 trial

  42. [68Ga]Ga-PentixaFor

    CERO THERAPEUTICS HOLDINGS, INC.

    triple-negative breast cancer

    phase 1 small molecule active

    1 trial

  43. [68Ga]MLN6907

    Takeda

    Imaging of Solid Gastrointestinal Tumors

    phase 1 small molecule completed

    1 trial

  44. [^14C]-alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  45. acetylsalicylic acid

    United Therapeutics Europe Ltd

    Precancerous Condition

    phase 1 small molecule completed

    1 trial

  46. aflibercept

    Regeneron UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule completed

    1 trial

  47. aflibercept (AVE0005)

    Regeneron UK Limited

    Neoplasms

    phase 1 small molecule completed

    2 trials

  48. aflibercept (AVE0005)

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,568 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.